Kidney Disease Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis

The Kidney Disease Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Kidney Disease Market Size and Its Estimated Growth Rate?
In the past few years, the kidney disease market has significantly expanded. The market valuation, projected to swell from $107.29 billion in 2024 to $114.74 billion in 2025, exhibits a compound annual growth rate (CAGR) of 6.9%. Factors such as increasing chronic health issues, an aging population, genetic factors, advancements in medical research and education, and environmental influences can account for this historical growth period.

In the coming years, the market size for kidney diseases is forecasted to see a robust growth, expanding to a value of $149.44 billion in 2029 with a compound annual growth rate (CAGR) of 6.8%. The growth projected in the forecast period is credited to the management of international infectious diseases, precision medicine methodologies, the widespread nature of diabetes and obesity, alterations in healthcare policies, and increased cognizance and screening. The major trends predicted during the forecast period involve the utilization of telemedicine for kidney care, attention to preventive nephrology, the increase in home-based dialysis, the progression of regenerative therapies, and adjustments in diet and nutrition.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11938

How Are Emerging Segments Shaping the Kidney Disease Market Landscape?
The kidney disease market covered in this report is segmented -

1) By Treatment: Medication, Dialysis, Surgery, Other Treatments
2) By Indication: Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indication
3) By Route Of Administration: Oral, Parenteral
4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users

Subsegments:
1) By Medication: Antihypertensives, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Vitamin D Analogs, Immunosuppressants
2) By Dialysis: Hemodialysis, Peritoneal Dialysis
3) By Surgery: Kidney Transplant, Nephrectomy, Renal Artery Bypass, Ureteral Surgery
4) By Other Treatments: Lifestyle And Dietary Modifications, Renal Replacement Therapy, Palliative Care

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11938&type=smp

Which Growth Factors Are Influencing Kidney Disease Market Expansion?
The growth of the kidney disease market is predicted to surge in response to the rising occurrence of kidney diseases. The term kidney diseases pertains to a collection of disorders that negatively impact the kidneys' functionality and structure. These medication treatments aim to decrease blood pressure, minimize protein loss, halt the advancement of kidney damage, manage symptoms and ward off any potential complications. For instance, according to Kidney Research UK, a charity based in the UK that focuses on research and advocacy to enhance the understanding, prevention and treatment of kidney diseases, it was reported that roughly 7.19 million people in the UK suffered from chronic kidney disease in June 2023. This figure, which represents over 10% of the UK population, is predicted to grow to an alarming 7.61 million people by 2033. Therefore, this mounting occurrence of kidney diseases is steering the growth of the kidney disease market.

Who Are the Dominant Players Across Different Kidney Disease Market Segments?
Major companies operating in the kidney disease market include Pfizer Inc., Johnson & Johnson Ltd., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi Aventis LLC, Bristol-Myers Squibb Company, AstraZeneca Pharmaceuticals LP, Abbott Laboratories, Fresenius SE & Co. KGaA, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Vertex Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Kyowa Kirin Co. Ltd., Cipla Inc., Endo International plc., Lupin Limited, Kissei Pharmaceutical Co. Ltd.

What Are the Latest Developing Trends in the Kidney Disease Market?
The growing trend in the kidney disease market is the incorporation of AI-enabled tools. To facilitate superior patient results and maintain their market presence, companies within the kidney disease sector are embracing innovative technologies. For example, Carenostics, a healthcare startup from the US that specializes in AI solutions, introduced its first product in November 2022. This product is designed to evaluate electronic health record (EHR) data for the early detection of chronic kidney disease (CKD). Carenostics smoothly incorporates AI-enhanced clinical decision support models into the EHR systems of healthcare providers. This amalgamation aids clinicians in accurately identifying patients at high risk of chronic diseases, allowing them to take preemptive actions for improved patient results.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Which Geographic Regions Are Expected to Dominate the Kidney Disease Market in the Coming Years?
North America was the largest region in the kidney disease market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Kidney Disease Market?
2. What is the CAGR expected in the Kidney Disease Market?
3. What Are the Key Innovations Transforming the Kidney Disease Industry?
4. Which Region Is Leading the Kidney Disease Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.